General Statement of Disclosure:

CONSULTING FEES/HONORARIA: Biomarin Pharmaceuticals(MODEST), Bayer Healthcare Pharmaceuticals(MODEST), Baxalta - Shire -Takeda(SIGNIFICANT), Bioverativ(SIGNIFICANT), CSL Behring (MODEST), Catalyst Biosciences(MODEST), Genentech/Roche(MODEST), Hema Biologics(MODEST), Novo Nordisk Inc.(MODEST)

View Full Disclosure